• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.

作者信息

Nace Heather, Lorber Bennett

出版信息

J Antimicrob Chemother. 2010 Jun;65(6):1315-6. doi: 10.1093/jac/dkq113. Epub 2010 Apr 7.

DOI:10.1093/jac/dkq113
PMID:20375035
Abstract
摘要

相似文献

1
Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.用替拉万星成功治疗耐甲氧西林金黄色葡萄球菌心内膜炎。
J Antimicrob Chemother. 2010 Jun;65(6):1315-6. doi: 10.1093/jac/dkq113. Epub 2010 Apr 7.
2
Cost-effectiveness analysis of treatment of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis is a difficult issue.耐甲氧西林金黄色葡萄球菌菌血症和心内膜炎治疗的成本效益分析是一个难题。
Clin Infect Dis. 2009 Sep 1;49(5):699-701. doi: 10.1086/604711.
3
Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.替拉万星治疗耐甲氧西林金黄色葡萄球菌菌血症和感染性心内膜炎。
Infect Dis (Lond). 2015 Jun;47(6):379-84. doi: 10.3109/00365548.2014.995696. Epub 2015 Mar 6.
4
[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].[耐甲氧西林金黄色葡萄球菌所致菌血症和心内膜炎治疗的共识文件。西班牙传染病与临床微生物学会]
Enferm Infecc Microbiol Clin. 2009 Feb;27(2):105-15. doi: 10.1016/j.eimc.2008.09.003. Epub 2009 Feb 11.
5
Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.达托霉素治疗失败后，采用利奈唑胺和替拉万星序贯单药治疗成功治愈耐甲氧西林金黄色葡萄球菌二尖瓣心内膜炎。
J Antimicrob Chemother. 2011 Sep;66(9):2186-8. doi: 10.1093/jac/dkr234. Epub 2011 Jun 8.
6
Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.替考拉宁在耐甲氧西林金黄色葡萄球菌或万古霉素中介金黄色葡萄球菌所致兔主动脉瓣心内膜炎模型中的疗效
Antimicrob Agents Chemother. 2005 Aug;49(8):3163-5. doi: 10.1128/AAC.49.8.3163-3165.2005.
7
Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.高剂量达托霉素成功用于一名患金黄色葡萄球菌性心内膜炎的儿童。
Pediatr Infect Dis J. 2016 May;35(5):517-8. doi: 10.1097/INF.0000000000000958.
8
Serious infections caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的严重感染。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S183-97. doi: 10.1086/653519.
9
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.一名耐甲氧西林金黄色葡萄球菌心内膜炎的肝移植受者在利奈唑胺和万古霉素治疗失败后，使用达托霉素成功进行挽救治疗。
Transpl Infect Dis. 2009 Aug;11(4):346-8. doi: 10.1111/j.1399-3062.2009.00403.x. Epub 2009 May 21.
10
[Treatment of mitral MRSA endocarditis using daptomycin].[使用达托霉素治疗二尖瓣耐甲氧西林金黄色葡萄球菌心内膜炎]
Med Mal Infect. 2008 Dec;38 Spec No 2:13-5. doi: 10.1016/S0399-077X(08)75154-0.

引用本文的文献

1
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis.用于治疗革兰氏阳性菌感染的新一代抗生素：聚焦心内膜炎和骨髓炎的综述
J Clin Med. 2021 Apr 17;10(8):1743. doi: 10.3390/jcm10081743.
2
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™).特拉万星治疗菌血症和心内膜炎患者的临床经验：来自特拉万星观察性使用登记处（TOUR™）的真实世界结果。
Drugs Real World Outcomes. 2020 Sep;7(3):179-189. doi: 10.1007/s40801-020-00191-x.
3
Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.
耐甲氧西林金黄色葡萄球菌人工心脏瓣膜心内膜炎：病理生理学、流行病学、临床表现、诊断和治疗。
Clin Microbiol Rev. 2019 Feb 13;32(2). doi: 10.1128/CMR.00041-18. Print 2019 Mar 20.
4
Methicillin-resistant bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality.肝移植受者中的耐甲氧西林菌血症：发病率、死亡率的流行病学及相关危险因素
Infect Drug Resist. 2018 May 3;11:647-658. doi: 10.2147/IDR.S161180. eCollection 2018.
5
Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.替考拉宁单独及与氨苄西林联合治疗粪肠球菌心内膜炎大鼠模型的疗效
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.02489-16. Print 2017 Jun.
6
In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure.替考拉宁对甲氧西林敏感和耐药金黄色葡萄球菌进行人体模拟暴露的体外药效学研究，有无万古霉素预暴露情况均包括在内。
Antimicrob Agents Chemother. 2015 Oct 19;60(1):222-8. doi: 10.1128/AAC.02033-15. Print 2016 Jan.
7
Update on the emerging role of telavancin in hospital-acquired infections.特拉万星在医院获得性感染中新兴作用的最新进展。
Ther Clin Risk Manag. 2015 Apr 13;11:605-10. doi: 10.2147/TCRM.S57376. eCollection 2015.
8
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus.替考拉宁在革兰氏阳性病原体所致菌血症感染中的潜在作用：聚焦于金黄色葡萄球菌。
Clin Infect Dis. 2015 Mar 1;60(5):787-96. doi: 10.1093/cid/ciu971. Epub 2014 Dec 3.
9
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.替考拉宁与标准治疗方案用于非复杂性金黄色葡萄球菌菌血症患者的随机2期试验：ASSURE研究
BMC Infect Dis. 2014 May 23;14:289. doi: 10.1186/1471-2334-14-289.
10
Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?由条纹棒状杆菌引起的 Native 瓣膜心内膜炎伴异质性高水平达托霉素耐药：达托霉素治疗的附带损害？
Antimicrob Agents Chemother. 2012 Jun;56(6):3461-4. doi: 10.1128/AAC.00046-12. Epub 2012 Mar 26.